ON THURSDAY, the Massachusetts Senate passed another ill-considered piece of legislation, Senate Bill 2651, that would impose price controls on one of Massachusetts most important economic sectors, biopharmaceuticals. The bill […]
price controls
Posted inHealth Care, Opinion
The folly of Baker’s drug price control plan
WHEN THE Biotechnology Industry Organization (BIO) selected Charlie Baker as Governor of the Year in 2018, the group may have misjudged Baker’s understanding of the industry. Baker recently offered legislation that […]